MIGUEL JOSÉ
MARTÍN JIMÉNEZ
Catedrático de universidad
![Foto de MIGUEL JOSÉ](/img/nophoto.png)
![Foto de University of Texas Southwestern Medical Center](/img/noimage_org.png)
University of Texas Southwestern Medical Center
Dallas, Estados UnidosPublications en collaboration avec des chercheurs de University of Texas Southwestern Medical Center (2)
2022
-
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
Journal for immunotherapy of cancer, Vol. 10, Núm. 2
2013
-
A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer
European Journal of Cancer, Vol. 49, Núm. 18, pp. 3763-3772